Study details
Enrolling now
Azithromycin for Critical Asthma - Pediatrics
Johns Hopkins All Children's Hospital
NCT IDNCT06223828ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
100
Study length
about 2.7 years
Ages
3–17
Locations
1 site in FL
About this study
Researchers are testing whether azithromycin helps children with critical asthma. The trial will measure how azithromycin affects the immune system in these children, and also look at potential side effects of azithromycin.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Azithromycin
PhasePhase 2/Phase 3
DrugAzithromycin
Routeinjection
Primary goalDrug-related adverse event rate (Primary Safety Endpoint)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low5%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
azithromycin
Drug routes
injection, intravenous
Endpoints
Primary: Drug-related adverse event rate (Primary Safety Endpoint)
Secondary: Length of Stay (Secondary Clinical Efficacy Endpoint)
Body systems
Respiratory